bioavailability-995x60.png bioavailability-995x60.png

FEATURED ARTICLES

How Do I Get My Compound Into Phase I?
How Do I Get My Compound Into Phase I?

The primary challenge for pharmaceutical and biotechnology companies in developing their drugs is to carefully assess the relationship between efficacy and toxicity prior to entering into human clinical trials. By Dr. Scott E. Boley and Greg Ruppert

More Featured Articles

WHITE PAPERS AND CASE STUDIES

  • Accelerating Preclinical Studies With Project Tracking And Optimization Software

    A large pharmaceutical company with globally distributed preclinical R&D operations including externalized services implemented an advanced assay/ study tracking and optimization system in conjunction with its enterprise electronic lab notebook.

  • Brochure: Norwich Clinical Services

    Norwich Clinical Services is a contract research organization that provides Bioanalytical Services, Pharmacovigilance and Clinical Research Programs to the pharmaceutical and biotech industries.

  • Ethnic Bridging

    Clinilabs, a contract research organization (CRO), was selected to characterize the pharmacokinetic prole of XXXX following the administration of four doses of XXXX to healthy Japanese and non-Japanese subjects aged 20 to 45 years by assessing serum concentration data over time.

  • ICON Clinical Development Overview

    ICON is one of the world’s largest providers of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialise in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies.

  • PK/PD Modeling & Simulation Datasheet ICON Development Solutions has industry-recognized expertise in the application and presentation of pharmacokinetic (PK) and pharmacodynamic (PD) principles critical for successful drug approval, with experience over the past 5 years that includes the following.
  • Special Populations: Renal And Hepatic Impairment Datasheet

    ICON’s experience supporting early phase studies in subjects with renal and hepatic impairment, as well as our close contact with local IRBs, allows our team to expedite study start-up project activities and meet enrollment objectives.

More White Papers & Case Studies

SERVICES AND PRODUCTS

Bioanalytical Laboratories Bioanalytical Laboratories

With over 1,500 assays developed in support of over 2,500 studies and with management experience averaging 21 years, ICON Development Solutions has the bioanalytical expertise and track record required to deliver rapid, dependable results. 

PK/PD Modeling & Simulation PK/PD Modeling & Simulation

ICON Development Solutions has industry-recognized expertise in the application and presentation of pharmacokinetic (PK) and pharmacodynamic (PD) principles critical for successful drug approval, with experience over the past 5 years that includes the following.

Clinical Pharmacology Clinical Pharmacology

The clinical pharmacology team at ICON Development Solutions (ICON) has extensive experience in the design, study conduct and interpretation of clinical pharmacology studies across all major therapeutic areas.

Clinical Research Clinical Research
Located on the campus of Cauvery Medical Centre in Bangalore, India, the 72-bed clinical facility contains separate areas for subject screening and blood draws, an on-site pharmacy and a state-of-the-art, fully equipped intensive care unit.
Pharmacokinetic And Pharmacodynamic Services Pharmacokinetic And Pharmacodynamic Services
SGS provides an extensive pharmacokinetic (PK) and pharmacodynamic (PD) support in pre-clinical and Phase I-III clinical studies in accordance with international regulatory standards (FDA, EMEA, ICH).
Bioanalytical Services Bioanalytical Services

For over 20 years, the bioanalytical services group of ICON Development Solutions has provided analytical testing services to meet the research and development challenges of the pharmaceutical and biotechnology industries.

More Services & Products

NEWS

More News